viernes, 20 de septiembre de 2013

Today’s articles on Investing Ideas

Alpha-Rich Ideas

LSI Looks Like A Compelling Buy Ahead Of A Solid 2014
by Ashraf Eassa

Editor's notes: Share gains in the hard disk SoC and pre-amp markets could lead to 50%+ upside for this fabless semi.

3 Reasons Why Sanofi Rights (GCVRZ) Could Return 50% This Year
by Chris DeMuth Jr.

Editor's notes: Approval of Lemtrada, which hedge fund manager Chris DeMuth deems likely, would lead to substantial upside for the GCVRZ security. 50% return in the short term; greater potential over time.

Indosat Is The Baby That Was Thrown Out With The Bathwater
by Mike Arnold

Editor's notes: The recent Indonesia-related sell-off has left ISAT.JK's shares unreasonably undervalued. 30% upside after factoring in liquidity, currency, and macro risks.

Costar Technologies: Asymmetric Risk/Reward, Discount To Book Despite 20%+ ROE
by Money Treez

Editor's notes: CSTI.PK is trading at a deep discount to peers and book value despite posting high returns and having strong growth prospects. Triple-digit upside for this micro cap.

Stocks Moving From Alpha-Rich Ideas

On September 9, Ashraf Eassa showed how a new product cycle, recent redesigns, and a cheap valuation made Emulex a buy. The stock is +8.9% since. Read article »

On August 16, Street Smart Investor said a cash inflow from a JV would allow Deep Sea Supply to take advantage of tailwinds in the offshore drilling industry. The shares are +24.3% to date. Read article »

Breaking Alpha-Rich Ideas (for Pro Subscribers. Learn more»)

This Company Is Winning And So Can You - 50% Upside Going Forward by Shaun Currie, CFA

Good Returns For Above-Average Risks by Stephen Simpson, CFA

Activist Bets Half The Fund On This Company, An Imminent Catalyst For 70% Upside by Kingsley Park Capital

An Underappreciated, Long-Term Play On Cloud Computing by Vince Martin

Long Ideas

Can Sanofi Get Back On Track? by Shankar N

Apogee Enterprises: Long-Term Thesis Intact Despite Soft Quarter by Alan Brochstein

Starbucks' Caffeine High Can Continue by Douglas Ehrman

2 Wins Goldman Sachs Can Tweet About by Douglas Ehrman

Silver Wheaton Remains The Best Play In Metals by Douglas Ehrman

Good Entry Point For Manchester United Shares With Record Revenue And Conservative Guidance by Chris Katje

Clovis: After Data, Company Looking For Acquisition by Brian L. Wilson

Neuralstem: Evidence Increasingly Suggests Its Neural Stem Cells Are Effective In ALS by Smith On Stocks

Why AbbVie Is A Solid Buy by Fusion Research

IBM: Right Move At The Right Time? by Fusion Research

This Could Be The Best Way To Play $1,500 Gold by Steve Nicastro

Sunshine Heart Stock Offering: Why Now? by Robert Honeywill

Rofin-Sinar Looking To A Cyclical Recovery And Fiber Share Gains by Stephen Simpson, CFA

Still Some Meat Left On Lockheed? by Fusion Research

It May Soon Be Time To Be Bullish On Hewlett-Packard by Michael Blair

Is Biodel A Buy Or Sell? by C.R. Jackson

Buy Blackberry, Even If No One Bids On It by George Kesarios

Comcast: The Story Through The Numbers by Valuentum

Gentiva Health Services's Excellent Acquisition Of Harden Healthcare by The Value Investor

A Company That Has Been Lining The Pockets Of Its Shareholders For Years by Bill Gunderson

Pandora Media At Its 52-Week High Before Delivering Shares by Prescient Investment Analysis

Why Has Antares Pharma Fallen So Rapidly? by Michael Luo

Can Nokia Take Advantage Of The Self-Driving Car Craze? by Jacob Steinberg

Alcatel-Lucent: Remarkable Run Nowhere Near Running Out Of Steam by Boniface Murigu

Why We're Still Fans Of Google by Valuentum

Interested In A Holistic Research Approach For Home Depot? by Valuentum

Schlumberger Limited: Many Catalysts Will Drive This Undervalued Stock by Jeff Williams

BlackBerry Outlook Becoming Bleak by Alex Jordon

Super Buying Opportunity With Westsport by Fusion Research

Will Micron Ever Be Shareholder Friendly? by Electric Phred

Why A Bad Company Can Be A Good Stock: Best Buy by Valuentum

Northgate Plc: Unloved And Undervalued With Large Upside Potential by Fund Gurus

Apple Versus Intel: What's Going On Here? by Ashraf Eassa

Rockwood Holdings - Dilutive Divestiture Reduces Any Leftover Appeal by The Value Investor

Augusta Is Undervalued Based On The Advanced Status Of The Rosemont Project by jaberwock

Is Titan Bottoming Out? by Stephen Simpson, CFA

Zynga's Woes Continue by Sramana Mitra

Priceline Headed To $1215, Main 2 Reasons Why by The Oxen Group

Bank Of America: Outperformance For This Giant Not Over Yet by Aurora Analytics

Lantronix: A Stock Under $2 Poised To Climb Higher by Micro-Cap Gem Finder

Online Education Companies Facing New Disruption by David Waldron

Alaska Air Still Different, Still Undervalued by Stephen Simpson, CFA

Foot Locker: It's All About The Estimates by William Cikos

Sirius XM To Refinance 7.625% Debt; Is HoldCo Next? by Crunching Numbers

Sonic Corporation: No Longer On The Value Menu by Marshall Hargrave

Hecla Mining: A Safe Precious Metals Company With Growth To Come by Kevin Quon

Marathon Patent Group: A Small Patent Company With Big Potential by Boris Marjanovic

Xoom Offers An Opportunity Now That The Secondary Overhang Is Gone by Darspal S Mann

Can SandRidge Energy Revive Its Fortunes? by Fusion Research

Why Facebook Remains Undervalued by Jayson Derrick

Emerging Markets Revisited by Elliott R. Morss

Enterprise Product Partners: Several Reasons Why I'm Staying Bullish On This MLP by Heather Ingrassia

Finding The Right Plastic For Your Portfolio by Sean Weston

NVidia: Much More Than The Power Behind Gaming Computers by Geppe

Fly Leasing: 6.5% Yield With Potential For 30% Gain by Stone Fox Capital

International Bancshares: To Buy Or To Buy More? That Is The Question! by Profit Fan

Salesforce And Workday - Reaffirming The Partnership by Michael Fauscette

BlackBerry Could Double From Here by Chris Lau

Google: Investing In Human Health Is Healthy by Nicholas Kitonyi

Does Vringo Have A Plan Beyond Google? by Patent Plays

Schnitzer Steel: A Scrap King For Your Portfolio With More Than 45% Upside Potential by Gregory Vousvounis

Despite The Baby Blues, OvaScience Is A Strong Buy by Stock Doctor

Citi: Near-Term Pressures Remain But So Does Long-Term Potential by Price Point

Key Events Are Turning Our Attention Back To Rare Earths by Jake Mitchell

Monotype Imaging: Has This Bull Had Its Run? by Fusion Research

Jiayuan.com: Strong Balance Sheet But Needing To Reduce User Churn by Elephant Analytics

Wal-Mart Was Once A Great Stock Like Dollar Tree by Bill Gunderson

Short Ideas

Herbalife: Will Icahn Cash Out Sooner Than Not? by Matt Stewart

J.C. Penney: An Argument Against The Bulls by CMI Research

Fleetmatics Group PLC: Accounting Shenanigans Are Inflating Its Financials, While Insiders Sell Aggressively by Prescience Point

GeoInvesting Blows The Whistle On L&L Energy by The GeoTeam

Student Transportation's Business Is Very Overvalued by Trust Intelligence

Ebix: New Problems Emerge In Singapore, Sweden And India by Gotham City Research

Quick Picks & Lists

Why Take-Two Interactive Is Poised To Have A Great Quarter by Lorenzo De Plano

Non-Operating Unconsolidated Subsidiaries: Invested Capital Adjustment by David Trainer

Bear Of The Day: MicroStrategy by Zacks Investment Research

Bull Of The Day: La-Z-Boy by Zacks Investment Research

Microsft Shares Poised To Increase by Stock Traders Daily

The Nvidia Story Sounds Positive, But Risks Exist For Investors by Stock Traders Daily

Oracle - Same Story: Lack Of Revenue Growth Remains The Issue by The Value Investor

Why Investing In Used Cars Is A Great Idea by Renu Singh

I Knew These Stocks Would Outperform The Market: New Price Targets Make Them Still Very Attractive by Justin Giles

2 Speculative Energy Concerns For Under $5 by Bret Jensen

Pandora Raises Funds: What Company Is Next? by Bill Maurer

The Case For Hewlett-Packard by Dana Blankenhorn

Taper Or No Taper, The Market Is On Borrowed Time by George Kesarios

Cramer's Picks

Cramer's Mad Money - Why Bernanke Did The Right Thing (9/19/13) by SA Editor Miriam Metzinger

Cramer's Lightning Round - Don't Sell Celldex (9/19/13) by SA Editor Miriam Metzinger

Insider Ownership

Insiders Are Selling Diamondback Energy by Markus Aarnio

Tiger Media: Phillip Frost And Time Are On Your Side For This Speculative Turnaround Company by Charles Fox

BBM Spin-Off Could Create Short Exodus by Tufenk

IPO Analysis

IPO Preview: FireEye by IPOdesktop

IPO Preview: BIND Therapeutics by IPOdesktop

IPO Preview: Rocket Fuel by IPOdesktop

IPO Preview: ClubCorp Holdings by IPOdesktop

Bind's IPO: A Revolution In Drug Delivery by Peter Geschek

Why Investors Should Pretend Twitter Isn't Going Public by Samuel Rae

Twitter Is No Facebook by Intelligent Speculator

Covisint IPO Is A No-Go by Don Dion

Benefitfocus Becomes The Next Hot Cloud Software IPO, Soars 102% In Market Debut by Renaissance Capital IPO Research

China Montage Tech IPO Is A Buy by Don Dion


Why are you receiving this? You subscribed to Investing Ideas at Seeking Alpha.
Unsubscribe from this email or manage all your Seeking Alpha email choices here.

To ensure you receive these emails in the future, please add account@seekingalpha.com to your address book, contacts or list of safe senders.

Sent by Seeking Alpha, 345 7th Ave. Suite 1400 New York, NY 10001

No hay comentarios:

Publicar un comentario